Home | Doxinate for Patients | Site Map | Contact Us
DOXINATE for Doctors
More than Just Morning Sickness
NVP Vs Chemo induced Nausea
Doxinate - Unique features
Studies and Research
MOA of Doxinate
Neural Tube Defects
Folic acid in NTD
Doxinate plus
Prescribing Information
Feedback / Suggestions
Doxinate for Doctors/NVP
Many women who have to cope with NVP endure tremendous physical hardship. Their suffering may have a profound impact on family, work and social life. The most severe form of NVP is commonly referred to as Hyperemesis Gravidarum (HG). It is marked by persistent vomiting that leads to weight loss greater than 5% of pre-pregnancy weight and occurs in about 1% of pregnancies. Although NVP may be classified as mild, moderate or severe, the severity of nausea or vomiting may not adequately reflect the distress it causes.
The physical and emotional impact of NVP often results in feeling of anxiety and worry about its effect on the fetus. Apart from 47% working women with NVP feeling their job efficiency being reduced and 25% loosing time from house work, NVP is also cited as a reason for elective termination of pregnancy. This may not be surprising since NVP is comparable in severity to the nausea experienced by patients undergoing cancer chemotherapy.
Hence early recognition and management of NVP could have a profound effect on women’s health and quality of life during pregnancy.
Doxinate © 2012 Web Design by FTPL